Showing results (1-10 of 142) with videos related to
Sort By:
Pageof 15
Cancers|October 16, 2024
IDH2 Inhibitors Gain a Wildcard Status in the Cancer Therapeutics CompetitionRoberto Piva, Nariman Gharari, Maria Labrador, et al.Cancers|February 13, 2026
Dual Targeting of IDH2 and the Ubiquitin-Proteasome System Reveals a Functional Vulnerability in Breast Cancer ModelsNariman Gharari, Elisabetta Mereu, Beatrice Luciano, et al.Journal, Genetic Engineering & Biotechnology|February 16, 2023
Biosynthesis of a VLP-type nanocarrier specific to cancer cells using the BEVS expression system for targeted drug deliveryMohammad Sadegh Hashemzadeh, Nariman GharariCancers|April 3, 2021
The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple MyelomaTina Paradzik, Cecilia Bandini, Elisabetta Mereu, et al.Cancers|May 16, 2023
Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell LinesElisabetta Mereu, Damiano Abbo, Tina Paradzik, et al.Journal of Molecular Biology|August 26, 2021
Minireview: What is Known about SUMOylation Among NR4A Family Members?Fatéma Dodat, Sylvie Mader, Daniel LévesqueCardiovascular Research|October 14, 2003
Tamoxifen and ICI 182,780 negatively influenced cardiac cell growth via an estrogen receptor-independent mechanismIsabelle Mercier, Sylvie Mader, Angelino CalderoneCancers|April 24, 2019
Wild-Type IDH Enzymes as Actionable Targets for Cancer TherapyElisa Bergaggio, Roberto PivaCells|November 27, 2021
Positive Regulation of Estrogen Receptor Alpha in Breast TumorigenesisLucas Porras, Houssam Ismail, Sylvie MaderCells|July 29, 2020
Cholesterol as an Endogenous Ligand of ERRα Promotes ERRα-Mediated Cellular Proliferation and Metabolic Target Gene Expression in Breast Cancer CellsFaegheh Ghanbari, Sylvie Mader, Anie PhilipPageof 15